Test Price
1,900 AED✅ Home Collection Available
Myasthenia Gravis Panel Test in UAE | 1900 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by a DHA-licensed specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Myasthenia Gravis Panel is a specialized serological investigation designed to detect circulating autoantibodies targeting the neuromuscular junction, including anti-AChR, anti-MuSK, anti-LRP4, and anti-titin antibodies. This assay helps confirm the diagnosis of myasthenia gravis and differentiate it from other neuromuscular disorders.
| Feature | Our Myasthenia Gravis Panel | Standard ELISA Panel |
|---|---|---|
| Methodology | Radioimmunoassay (RIA) + Indirect Immunofluorescence Assay (IFA) | Enzyme-Linked Immunosorbent Assay (ELISA) only |
| Diagnostic Sensitivity | ≥99.9% (ISO quality controlled) | ~85% |
| Turnaround Time | 4 working days (sample Tuesday by 9 AM) | 7–10 working days |
| Antibodies Covered | AChR, MuSK, LRP4, Titin, Striational | Limited profile (usually AChR only) |
Physician Insight & Safety Protocols
“As a General Practitioner, I understand the importance of accurate serological testing for neuromuscular symptoms. The Myasthenia Gravis Panel provides objective immunological evidence that helps guide treatment decisions. However, results should always be interpreted alongside your clinical history and physical examination. Do not stop or change any prescribed medications without consulting your physician.” — Dr. Ajay Singh, DHA License 36234132
Medication Advisory
Important: Do not discontinue prescribed medication without consulting your doctor. The panel results are meant to assist, not replace, your current treatment plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients who have received general anaesthetic or muscle relaxant drugs within 24 hours prior to sampling should defer the test.
- Emergency Red Flags: If you experience sudden shortness of breath, severe difficulty swallowing, or rapidly worsening double vision, seek immediate emergency medical care.
Patient FAQ & Clinical Guidance
1. What is the Myasthenia Gravis Panel Test?
The Myasthenia Gravis Panel Test measures specific autoantibodies (AChR, MuSK, LRP4, titin) to diagnose myasthenia gravis and differentiate it from other neuromuscular disorders.
2. How should I prepare for the test?
Avoid general anaesthetics and muscle relaxant drugs for 24 hours before sample collection; only a serum sample is required.
3. When will I receive my results?
Samples collected by Tuesday 9 AM are processed, and reports are ready within 4 working days.
4. Can this test be done at home?
Yes, VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection are available daily from 8 AM to 11 PM for serum samples.
For any queries, contact +971 54 548 8731 (phone/WhatsApp).
UAE Regulatory & Data Privacy Adherence
Your Data, Protected
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access-controlled, and used solely for clinical diagnostic purposes. Laboratory operations are licensed by the Dubai Health Authority (DHA) under Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Myasthenia Gravis Panel (AChR, MuSK, LRP4, Titin, Striational) |
| Price (AED) | 1,900 AED |
| Turnaround Time | 4 working days (sample collected Tuesday by 9 AM) |
| Sample Type / Matrix | Serum (peripheral blood) |
| Methodology Used | Radioimmunoassay (RIA) + Indirect Immunofluorescence Assay (IFA) |
| ICD-10-CM Code | G70.0 (Myasthenia gravis) |
| LOINC Code | 13953-6 (Myasthenia gravis autoantibody panel) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians